https://www.aafp.org/pubs/afp/issues/2017/0115/p120.html
Umeclidinium (Incruse Ellipta) for COPD | AAFP
Umeclidinium is an easy-to-use, once-daily, well-tolerated, and relatively low-cost anti-cholinergic agent for maintenance therapy in patients with moderate to...
incruse elliptacopdaafp